| scholarly article | Q13442814 |
| P2093 | author name string | Min Liu | |
| Nisha J D'Silva | |||
| Keith L Kirkwood | |||
| Wenpu Zhao | |||
| P2860 | cites work | Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. | Q22010036 |
| AU binding proteins recruit the exosome to degrade ARE-containing mRNAs | Q24291926 | ||
| Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms | Q24292426 | ||
| MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay | Q24316111 | ||
| Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin | Q24323168 | ||
| Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover | Q24534314 | ||
| Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1 | Q28118675 | ||
| Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway | Q28350388 | ||
| Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability | Q28508664 | ||
| Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference | Q28589337 | ||
| A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency | Q28589649 | ||
| Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function | Q28609872 | ||
| p38 MAPK regulates IL-1beta induced IL-6 expression through mRNA stability in osteoblasts | Q33947764 | ||
| Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements | Q34065213 | ||
| Silencing mitogen-activated protein kinase-activated protein kinase-2 arrests inflammatory bone loss | Q34702307 | ||
| Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression? | Q35003449 | ||
| The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. | Q36026396 | ||
| Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma | Q36616576 | ||
| Rapid transit in the immune cells: the role of mRNA turnover regulation. | Q36776927 | ||
| p38 MAPK signaling in oral-related diseases | Q36919722 | ||
| The blockade of IL-6 signaling in rational drug design | Q37160974 | ||
| Control of mRNA decay by phosphorylation of tristetraprolin. | Q37164616 | ||
| Cytokines in colitis associated cancer: potential drug targets? | Q37265020 | ||
| Targeting mRNA stability arrests inflammatory bone loss | Q37364464 | ||
| Targeted therapies in multiple myeloma | Q37431609 | ||
| Interleukin-6 as a therapeutic target in candidate inflammatory diseases | Q37698197 | ||
| The TIS11 primary response gene is a member of a gene family that encodes proteins with a highly conserved sequence containing an unusual Cys-His repeat | Q38336281 | ||
| ARED 2.0: an update of AU-rich element mRNA database. | Q38430539 | ||
| Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. | Q39655080 | ||
| A dominant function of p38 mitogen-activated protein kinase signaling in receptor activator of nuclear factor-kappaB ligand expression and osteoclastogenesis induction by Aggregatibacter actinomycetemcomitans and Escherichia coli lipopolysaccharide | Q40008685 | ||
| Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor | Q40174280 | ||
| Actinobacillus actinomycetemcomitans lipopolysaccharide induces interleukin-6 expression through multiple mitogen-activated protein kinase pathways in periodontal ligament fibroblasts | Q40215927 | ||
| MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells | Q40221732 | ||
| Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 | Q40620791 | ||
| Gene suppression by tristetraprolin and release by the p38 pathway | Q40795321 | ||
| The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. | Q41850515 | ||
| p38alpha stabilizes interleukin-6 mRNA via multiple AU-rich elements | Q42049265 | ||
| Serum levels of interleukin 6 and stress related substances indicate mental stress condition in patients with rheumatoid arthritis. | Q43571084 | ||
| A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA. | Q44467307 | ||
| AU-rich transient response transcripts in the human genome: expressed sequence tag clustering and gene discovery approach. | Q45241844 | ||
| Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability | Q73520889 | ||
| Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma | Q77357301 | ||
| A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss | Q79240430 | ||
| P433 | issue | 8 | |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 629-637 | |
| P577 | publication date | 2011-04-03 | |
| P1433 | published in | Journal of Interferon and Cytokine Research | Q15754749 |
| P1476 | title | Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region | |
| P478 | volume | 31 |
| Q89892713 | A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis |
| Q33919012 | A balancing act: RNA binding protein HuR/TTP axis in endometriosis patients |
| Q45328178 | Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics |
| Q39092491 | An Ancient Family of RNA-Binding Proteins: Still Important! |
| Q39793622 | An RNA element in human interleukin 6 confers escape from degradation by the gammaherpesvirus SOX protein |
| Q36915432 | Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo |
| Q47329135 | Aryl hydrocarbon receptor inhibits inflammation in DSS‑induced colitis via the MK2/p‑MK2/TTP pathway |
| Q64084853 | BAG3 Suppresses Loading of Ago2 to IL6 mRNA in Pancreatic Ductal Adenocarcinoma |
| Q92422034 | Cardiovascular inflammation: RNA takes the lead |
| Q90370698 | Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation |
| Q39225975 | Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages |
| Q35757055 | Dominant Suppression of Inflammation via Targeted Mutation of the mRNA Destabilizing Protein Tristetraprolin |
| Q34200816 | Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy |
| Q47773805 | Endonuclease Regnase-1/Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) in controlling immune responses and beyond |
| Q36607631 | Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies |
| Q38601736 | Extracellular vesicles as immune mediators in response to kidney injury |
| Q42251092 | Gain-of-Function Mutation of Tristetraprolin Impairs Negative Feedback Control of Macrophages In Vitro yet Has Overwhelmingly Anti-Inflammatory Consequences In Vivo. |
| Q36675764 | Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6. |
| Q36668282 | LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP |
| Q50848206 | Luteolin inhibits inflammatory responses via p38/MK2/TTP-mediated mRNA stability. |
| Q47163455 | Luteolin: A Flavonoid that Has Multiple Cardio-Protective Effects and Its Molecular Mechanisms |
| Q35725536 | MAPK usage in periodontal disease progression |
| Q35237725 | MAPK-activated protein kinase 2-deficiency causes hyperacute tumor necrosis factor-induced inflammatory shock. |
| Q42212083 | MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T-cell development upon influenza A virus infection |
| Q64115759 | MAPKAPK2: the master regulator of RNA-binding proteins modulates transcript stability and tumor progression |
| Q35901101 | MicroRNA-9 promotion of interleukin-6 expression by inhibiting monocyte chemoattractant protein-induced protein 1 expression in interleukin-1β-stimulated human chondrocytes |
| Q35601698 | MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro |
| Q42039351 | Multilevel regulation of HIF-1 signaling by TTP. |
| Q36175247 | Placental-mediated increased cytokine response to lipopolysaccharides: a potential mechanism for enhanced inflammation susceptibility of the preterm fetus |
| Q38238033 | Post-transcriptional gene regulation by RNA-binding proteins in vascular endothelial dysfunction |
| Q39042850 | RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins |
| Q35984488 | RNA-stabilizing proteins as molecular targets in cardiovascular pathologies. |
| Q39215435 | Regulation of mRNA stability by CCCH-type zinc-finger proteins in immune cells |
| Q38819007 | Regulation of the Expression of Heparan Sulfate 3-O-Sulfotransferase 3B (HS3ST3B) by Inflammatory Stimuli in Human Monocytes |
| Q36235672 | Sustained mitogen-activated protein kinase activation with Aggregatibacter actinomycetemcomitans causes inflammatory bone loss |
| Q38975045 | TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a |
| Q33623170 | The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer |
| Q52631846 | The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells. |
| Q41887469 | The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation |
| Q28076811 | The control of inflammation via the phosphorylation and dephosphorylation of tristetraprolin: a tale of two phosphatases |
| Q37119721 | Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action |
| Q51765173 | Tristetraprolin Is Required for Alveolar Bone Homeostasis. |
| Q99404874 | Tristetraprolin Regulates TH17 Cell Function and Ameliorates DSS-Induced Colitis in Mice |
| Q37080841 | Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation |
| Q37990333 | Tristetraprolin: roles in cancer and senescence |
| Q36356966 | miR-139 modulates MCPIP1/IL-6 expression and induces apoptosis in human OA chondrocytes |
Search more.